Cargando…
Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer’s disease: findings based on urine proteomics and machine learning
BACKGROUND: Alzheimer’s disease is a prevalent disease with a heavy global burden. Proteomics is the systematic study of proteins and peptides to provide comprehensive descriptions. Aiming to obtain a more accurate and convenient clinical diagnosis, researchers are working for better biomarkers. Uri...
Autores principales: | Wang, Yuye, Sun, Yu, Wang, Yu, Jia, Shuhong, Qiao, Yanan, Zhou, Zhi, Shao, Wen, Zhang, Xiangfei, Guo, Jing, Zhang, Bin, Niu, Xiaoqian, Wang, Yi, Peng, Dantao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625308/ https://www.ncbi.nlm.nih.gov/pubmed/37925455 http://dx.doi.org/10.1186/s13195-023-01324-4 |
Ejemplares similares
-
Plasma tau proteins for the diagnosis of mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis
por: Chen, Leian, et al.
Publicado: (2022) -
Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer’s disease
por: Zhang, Bin, et al.
Publicado: (2023) -
The Association Between Plasma α-Synuclein (α-syn) Protein, Urinary Alzheimer-Associated Neuronal Thread Protein (AD7c-NTP), and Apolipoprotein Epsilon 4 (ApoE ɛ4) Alleles and Cognitive Decline in 60 Patients with Alzheimer’s Disease Compared with 28 Age-Matched Normal Individuals
por: Lv, Shuang, et al.
Publicado: (2021) -
Genetic Insights into Obesity and Brain: Combine Mendelian Randomization Study and Gene Expression Analysis
por: Chen, Leian, et al.
Publicado: (2023) -
Identification of TLR2 as a Key Target in Neuroinflammation in Vascular Dementia
por: Wang, Yuye, et al.
Publicado: (2022)